The first batch of doses will cost €63 mil. FMTNews Covid19
BRUSSELS: The European Commission has ordered 30,000 treatment doses of the antiviral medication remdesivir from US drugs giant Gilead, it announced Wednesday.
Sold under the brand name Veklury, remdesivir is the first medicine to be approved by the EU to treat victims of the Covid-19 pandemic in EU member states and Britain. It is hoped the drug will shorten recovery times for patients with severe infections and it will be made available early next month. The first batch of doses will cost €63 million and ought to cover needs for the next few months before a second procurement contract in October.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
30-day grace period for PLKS holders - Deputy MinisterKUALA LUMPUR: The Home Ministry has given a 30-day grace period to holders of Temporary Employment Visit Pass (PLKS) that expired during the enforceme...
Read more »
Loan moratorium expiry: Here's what happens after Sept 30UPDATED 3.46PM | Prime Minister Muhyiddin Yassin announces targeted reliefs for certain segments of society who may still need help.
Read more »
KDN beri pas khas 30 hari, urus pelanjutan Permit Lawatan Kerja Sementara | The Malaysian InsightDari 1 Jan hingga 2 Julai, seramai 2,766 daripada 1,545,101 pemegang PLKS ditangkap atas kesalahan menetap lebih masa setelah tamat tempoh permit.
Read more »
30 days to renew migrant worker permits that expired during MCO | The Malaysian InsightThis is to help employers who need workers, deputy minister tells Parliament.
Read more »
Facebook worried EU anti probe invades the privacy of their employeesSAN FRANCISO: Facebook on Monday said it is asking EU courts to review “exceptionally broad” requests by antitrust regulators there that would scoop u...
Read more »